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Abstract: The present study had three main aims: (1) to explore the possible relationships between the
two dimensions of negative symptoms (NS) with the three frontal behavioral syndromes (dorsolateral,
orbitofrontal and the anterior or mesial cingulate circuit) in patients with schizophrenia; (2) to
determine the influence of sociodemographic and clinical variables on the severity of the two
dimensions of NS (expressive deficits and disordered relationships/avolition); and (3) to explore the
possible relationships between the two dimensions of NS and social functioning. We evaluated a
group of 33 patients with schizophrenia with a predominance of NS using the self-reported version
of the Frontal System Behavior scale. To quantify the severity of NS, the Assessment of Negative
Symptoms (SANS) scale was used. The results revealed that the two dimensions of NS correlate
positively with the behavioral syndrome of dorsolateral prefrontal origin. Regarding the influence of
sociodemographic and clinical variables, in patients with a long evolution the NS of the expressive
deficits dimension were less severe than in patients with a short evolution. A negative correlation
was found between the severity of NS of the disordered relationships/avolition dimension and
perceived social functioning. Our results show the importance of differentiating between the two
dimensions of NS to characterize better their possible frontal etiology and impact on clinical course
and social functioning.
Keywords: schizophrenia; negative symptoms; fronto-subcortical syndromes; social functioning
1. Introduction
Negative symptoms (NS) in schizophrenia patients are defined as a decrease in normal
functioning and behavior and have been mostly related to poor functional outcomes,
producing a clear impact on family, social and occupational aspects [1]. Specifically, the
five NS that are usually present in schizophrenia are: (1) flattening of affect, defined as a
decrease in facial expression of emotions, eye contact and other movements that accompany
speech; (2) alogia or decrease in verbal production or expressiveness; (3) avolition or apathy,
defined as reduced initiation and persistence of goal-directed activity due to decreased
motivation; (4) anhedonia or inability to experience pleasure from positive stimuli; and
(5) asociality, understood as a reduction in social activity and a reduced interest or desire
for establishing relationships with others [2].
Due to the impact of these symptoms on the patient, the study of these has increased
considerably. Thus, some authors, through factor analysis studies, have reported the exis-
tence of two different factors that cover all the variability of NS. Specifically, this approach
proposes the presence of two different dimensions of NS: a dimension of expressive deficits
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(also referred to as a decrease in emotional expression or expression factor), which includes
the symptoms of flattened affect and alogia, and a second dimension that constitutes the
factor of disordered relationships (also referred to as avolition-apathy or experiential factor).
From now on, these will be referred to as disordered relationships/avolition which include
the symptoms of apathy/avolition and anhedonia/asociality [3–8].
Recently, some studies have tried to identify whether these two dimensions can be
distinguished from each other in terms of aspects such as work, social, demographic
factors and clinical features [9–11]. For example, Llerena et al. [12] explored whether
the two dimensions of NS were differentially related to work outcomes and found that
the NS of disordered relationships/avolition, but not expressive deficits, were associated
with fewer hours worked, poorer outcomes, lower wages and a lower probability of
obtaining employment.
Rocca et al. [13] examined the functional outcomes in real life of a sample of outpa-
tients, finding that disordered relationships/avolition was a more significant predictor
of social activity, interpersonal relationships and a greater likelihood of being single, in
addition to having greater stability in social symptoms. Likewise, Strauss et al. [14] report
that those patients with symptoms of the disordered relationships/avolition dimension
have been associated with worse social functioning and greater deficits in social cognition.
This association is important, because social functioning is a key factor for the maintenance
of patients in the community and constitutes a powerful predictor of the evolution of the
disease. Furthermore, social functioning is a significant predictor of whether an individual
may develop psychosis [15].
In this sense, different NS related to reduced motivation have been directly associated
with poor social functioning. For example, for authors like Horan et al. [16] anhedonia is a
fundamental factor underlying the disabling social isolation and emotional deterioration
that result in schizophrenia, being directly related to reduced motivation to participate in
social activities. Similarly, Schlosser et al. [17] reported a greater association between the
symptoms of disordered relationships/avolition with social functioning. In their study
they found that these symptoms were more predictive of social functioning compared to ex-
pressive deficits, suggesting that abulia and anhedonia are more important for determining
the level of social functioning than flattening of affect and alogia.
Regarding sociodemographic variables, expressive deficit symptoms have been mostly
related to the male gender, a lower age at onset of the disease [10,18] and have been
negatively correlated with years of schooling [18]. Expressive deficits have also been related
to a more impaired neuropsychological functioning, particularly deficits in executive
functions and working memory [9,18], and more variable symptoms throughout the course
of the disease [19,20]. Similarly, Gur et al. [21] reported a poorer quality of life in patients
with these symptoms. However, Ergül and Üçok [18] also note that this dimension is
related chiefly to asymptomatic remission after the first episode of the disease.
On the other hand, another important aspect to analyze regarding the two dimensions
of NS is whether they are related to behavioral alterations associated with the prefrontal
cortex. The prefrontal cortex (PFC) acts as a mediator in the specific functions carried
out by the other cortical and subcortical structures. In this regard, Alexander et al. [22]
identified a highly organized system of circuits that link portions of the frontal cortex with
the basal ganglia and the thalamus.
At present, three fronto-subcortical circuits have been described that could be related
to psychosis: (1) the dorsolateral circuit, which has its origins in the dorsolateral PFC with
projections to the caudate nucleus (dorsolateral), globus pallidus (lateral dorsomedial) and
thalamus (anterior ventral and medial dorsal); (2) the orbitofrontal circuit, which originates
in the lateral orbital cortex with projections to the caudate (ventromedial) nucleus, globus
pallidus (medial dorsomedial) and thalamus (ventral anterior and medial dorsal); and
(3) the anterior cingulate or mesial circuit, which includes the anterior cingulate cortex,
nucleus accumbens, globus pallidus (rostrolateral) and medial dorsal thalamus [23].
J. Clin. Med. 2021, 10, 3417 3 of 16
The interruption or failure of any of the structures of these circuits or their interconnec-
tions can produce, according to the affected area, a series of behavioral alterations [24], thus
generating one of the following syndromes: the dorsolateral syndrome, the orbitofrontal
syndrome or the anterior cingulate syndrome [25].
The dorsolateral syndrome is related to alterations in the most complex cognitive
processes. The primary manifestation of failure in this circuit is evident in the following
executive deficits: difficulties in planning, abstraction, working memory, fluency, mental
flexibility, generation of hypotheses and working strategies, seriation and sequencing [26].
The orbitofrontal syndrome has been related to the regulation of affect and social emo-
tions and behaviors, influencing behavioral disinhibition and emotional lability, along with
decision-making based on affective states [26]. Alterations in the orbitofrontal circuit have
also been related to the onset of uninhibited and self-centered behaviors and sometimes
manic and euphoric states. The patient shows hyperactive but unproductive behavior, with
emotionality ranging from euphoria to irritability, as well as a deficit in impulse control.
An alteration of this circuit appears to disconnect the frontal monitoring systems from the
limbic input [25].
The anterior cingulate syndrome has been related to apathy and its main manifesta-
tions are observed at the level of a deficit in emotional responses. Patients do not show
reactivity to emotional stimuli and usually have poor initiation skills [27].
If we consider the behavioral and emotional alterations of each of these three syn-
dromes that emerge as a result of an alteration of the fronto-subcortical circuits, essential
similarities can be observed with the manifestations of NS described in schizophrenic
patients [28–33]. These similarities lead us to speculate whether the dimensions of NS
(expressive deficits and disordered relationships/avolition) could be specifically related to
any of the behavioral alterations that have been linked to fronto-subcortical syndromes.
This latter question is relevant since it could help us to more precisely distinguish
both the characteristics and pathological mechanisms presented by each dimension. Like-
wise, given the symptomatic heterogeneity of schizophrenia, it could help to inform the
development of more targeted and effective interventions for cases of schizophrenia with
a predominance of NS. However, to our knowledge, no studies have explored the possi-
ble relationships between the two dimensions of NS (expressive deficits and disordered
relationships/avolition) and the behavioral alterations associated with the three frontal
behavioral syndromes.
Thus, the present study had three main objectives. First, we aimed to explore in
a sample of patients with schizophrenia with a predominance of NS the possible rela-
tionships between the two dimensions of NS (expressive deficits and disordered rela-
tionships/avolition) and the three frontal behavioral syndromes (dorsolateral prefrontal,
orbitofrontal and anterior cingulate or mesial). Second, we set out to study the influence of
sociodemographic (age, gender and years of education) and clinical variables (duration
of illness, pharmacological treatment and clinical setting to which the patient belonged)
on the severity of the two dimensions of NS (expressive deficits and disordered relation-
ships/avolition). Finally, we aimed to study the relationship between the two dimensions
of NS and the perception that patients have about their social functioning.
Considering the previous literature regarding our first objective, we expect that the
dimension of expressive deficits is positively correlated with the dysexecutive behav-
iors associated with the dorsolateral syndrome. The dimension of disordered relation-
ships/avolition would be expected to show a positive correlation with the behaviors
associated with the orbitofrontal syndrome, because in the scientific literature the areas
involved in this circuit have been related to changes in behavior, affecting interpersonal
relationships and social interaction. In the same way, we expect apathic behaviors to be
correlated with the anterior cingulate syndrome, since this dimension is characterized by a
marked decrease in emotional expression and symptoms of apathy.
Regarding our second objective, we expect to find that men show a greater severity
of symptoms of expressive deficits compared to women. With respect to the years of
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schooling, it would be expected that those patients with fewer years of schooling present
greater severity of symptoms of expressive deficits than those with more years of schooling.
Similarly, at the level of clinical variables, we expect that in this dimension of expressive
deficits, patients with a longer duration of the disease differ from those with a shorter
duration, since expressive deficits in the literature have been mainly associated with symp-
tomatic remission after the first episode of the disease and with more variable symptoms
throughout its evolution. Therefore, it would be expected that patients with a longer
evolution could present a lower score for this symptomatology. Likewise, it is also expected
that patients with a greater need for hospitalization differ significantly from those with
outpatient care, because expressive deficits have been associated with poorer functional
results over time.
With respect to social functioning, and according to data from the literature, we expect
that those patients who score higher in the symptoms of disordered relationships/avolition
will be those who have a lower score on the scale of social functioning (or those who show
a worse perception of their social functioning).
2. Materials and Methods
2.1. Participants
In the present study, 33 participants (24 men and 9 women) aged between 18 and
57 years (M = 44.4, SD = 9.0) participated from the mental health area of the city hospital.
The participants were recruited as part of a more extensive study exploring cognitive and
emotional executive functions in a sample of patients with psychosis [34]. All participants
included in the study had the following inclusion criteria: (1) definitive diagnosis of
schizophrenia (paranoid), (2) a minimum of two years of confirmed diagnosis, (3) state
compensated during the last months prior to the evaluation and (for this criterion, we had
the collaboration of the patient’s psychiatrist who confirmed a psychopathological stability
and active motivation to carry out the evaluation) (4) patients with a predominance of
NS confirmed by a higher percentage score on the Scale for the Assessment of Negative
Symptoms (SANS) than on the Scale for the Assessment of Positive Symptoms (SAPS).
The clinical and sociodemographic variables considered in this study can be seen
in Table 1.













Basic (<6) 17 (51.5)
Medium (7 and 12) 9 (27.3)
High (>12) 7 (21.2)







Years of evolution of the disease
Short evolution (less than 11 years) 16 (48.5)
Long evolution (more than 11 years) 17 (51.5)
Clinical setting
In hospital 18 (54.5)
Outpatient 15 (45.5)
Pharmacological treatment
Typical antipsychotics 4 (12.1)
Atypical antipsychotics 18 (54.5)
Typical and atypical antipsychotics 3 (9.1)
Other medications 8 (24.2)
2.2. Assessment
2.2.1. Negative Symptoms Assessment
The severity of NS was assessed using the Scale for the Assessment of Negative
Symptoms (SANS) [35] and the Scale for the Assessment of Positive Symptoms (SAPS) [36].
Scale for the Assessment of Negative Symptoms (SANS) [35]. Made up of 30 items and
5 subscales that cover the following different negative symptoms: (1) flattening of affect,
(2) alogia, (3) avolition-apathy, (4) anhedonia-asociality and (5) deterioration of attention.
Rated on a scale from 0 (absence) to 5 (severe). Higher scores indicate greater presence
and severity of NS. This scale also makes it possible to obtain a SN severity score from
the dimension of expressive deficits (flattening of affect, allegiance) and another symptom
severity score from the disordered relationships/withdrawal dimension (abulia-apathy,
anhedonia-asociality). This scale has good test–retest reliability and validity [7].
Scale for the Assessment of Positive Symptoms (SAPS) [36]. Consists of 34 items and
4 subscales associated with the following main positive symptoms: (1) hallucinations,
(2) delusions, (3) extravagant or strange behavior and (4) formal thought disorder. A score
is obtained based on a scale from 0 (absence) to 5 (severe). A higher score indicates a greater
presence and severity of positive symptoms. This scale has good test–retest reliability and
validity [7].
2.2.2. Behavioral Alterations Assessment
To identify and quantify the behavioral alterations associated with the three syndromes
of frontal origin, we used the Spanish version [37] of the Frontal Systems Behavior Scale
(FrSBe) [38]. This instrument consists of 46 items grouped into three independent subscales:
executive dysfunction (17 items), disinhibition (15 items), and apathy (14 items). The
scale provides a global measure of frontal deterioration but, in addition, depending on
the partial scores obtained in each subscale, it discriminates between the three above-
mentioned behavioral syndromes: dorsolateral prefrontal syndrome (executive dysfunction
subscale), orbitofrontal syndrome (disinhibition subscale) and anterior cingulate syndrome
(apathy subscale). This scale makes it possible to establish whether patients have clinically
significant scores to indicate any of the three behavioral syndromes of frontal origin. By
converting direct scores into standardized scores (T) according to the age, education and
gender of the participant, three ranges of affectation can be obtained according to their
cut-off point: no risk (<59 points); high risk or borderline (60 to 64); and clinically significant
(>65). The FrSBe has two profile forms: the self-rating profile form and the family rating
profile form. In the present study, only the self-rating profile form was used. The FrSBe has
shown adequate construct validity to evaluate these three behavioral syndromes [37].
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2.2.3. Social Functioning Assessment
To measure social functioning we used the Spanish adaptation [39] of the short version
of the Social Functioning Scale (SFS-HI) [40]. This scale was designed to evaluate patients’
perception of their social functioning. The scale has 15 items, providing a global score
between 0 and 45 points. It has shown good reliability and validity [39]. We also used the
domain of Social relationships of the quality of life questionnaire WHOQOL-BREF (World
Health Organization Quality of Life) in its Spanish version [41]. This domain denotes an
individual’s perception of personal relationships, social support and sexual activity.
2.3. Procedure
The patient’s attending professional (clinical psychologist or psychiatrist) adminis-
tered the SANS and the SAPS. At the same time, the other scales (FrSBe, SFS-HI and
WHOQOL-BREF) were applied by the researcher in a consultation. The scales were ad-
ministered in a quiet office and took between 30 and 40 min to complete. These scales
were completed by the investigator or by the patients, according to the preference of the
patients themselves, always ensuring that they understood the instructions correctly and
were sufficiently motivated to carry out the task. The procedure to establish the predom-
inance of negative symptoms can be consulted in Ruiz-Castañeda et al. [34]. Once the
sample of patients with a predominance of negative symptomatology was obtained, the
scores of the two dimensions were obtained from the sum of the items of each dimension.
The alogia/flattening of affect scores (items 1 to 15) were summed for expressive deficits,
and apathy/asociality/anhedonia scores were summed (items 16 to 26) for disordered
relationship/avolition.
2.4. Statistical Analysis
To study the possible relationships between the two dimensions of NS and the three
frontal behavioral syndromes, Spearman correlation analyses were conducted between the
two SANS scores (expressive deficits and disordered relationships/avolition) and the three
FrSBe subscale scores (executive dysfunction, disinhibition and apathy).
To explore the possible influence of sociodemographic and clinical variables on
the severity of the two dimensions of NS, the following analyses were performed. To
test whether there were differences in the severity of the symptoms of the expressive
deficits dimension between men and women, the Mann-Whitney U test was used. To
explore the possible differences based on age, the patients were divided into two groups
(<44.4 years and >44.4 years) and the scores obtained by both age groups in this dimension
of NS were compared using the Mann–Whitney U test. To explore the influence of the
years of education, the patients were divided into three groups: basic (<6), medium (7 and
12) and high (>12), and their scores in the expressive deficits dimension were compared
with the Kruskal–Wallis test.
Regarding the clinical variables, for the pharmacological treatment the patients were
divided into four groups (typical antipsychotics, atypical antipsychotics, typical and atypi-
cal antipsychotics or other medications not related to psychotic illness) and their scores
were compared in this dimension of NS through the Kruskal–Wallis test. To explore the
influence of the clinical device to which the patients belonged (hospital or outpatient
treatment regimen) and the years of disease evolution (less than 11 years or more than
11 years), the comparison analyses were carried out through the Mann–Whitney U test.
These same comparison analyses were also performed with the scores obtained in the
disordered relationships/avolition dimension.
To analyze the relationship between social functioning and the two dimensions of NS,
Spearman correlation analyses were performed.
J. Clin. Med. 2021, 10, 3417 7 of 16
3. Results
3.1. Negative Symptoms and Frontal Behavioral Syndromes
As expected, the expressive deficits dimension only showed a positive and signifi-
cant correlation with the behavioral alterations associated with the dorsolateral prefrontal
syndrome (executive dysfunction subscale) (rho = 0.5, p = 0.003). Patients that scored
higher on the expressive deficits dimension also scored higher on the behavioral alterations
associated with dysfunction in the dorsolateral prefrontal circuit. However, our predictions
concerning the disordered relationships/avolition dimension were not supported, since a
significant and positive correlation was observed with the behavioral alterations associated
with the dorsolateral prefrontal syndrome (executive dysfunction subscale) (rho = 0.356,
p = 0.042), but the correlation with the behavioral alterations associated with the or-
bitofrontal syndrome (disinhibition subscale) and the anterior cingulate syndrome (apathy
subscale) was null (see Table 2).
Table 2. Correlations between the scores on the two dimensions of negative symptoms (disordered relationships/avolition





(Disinhibition) Anterior Cingulate (Apathy)
Expressive deficits 0.496 * 0.029 0.211
Disordered
relationships/avolition 0.356 ** −0.022 0.314
Dorsolateral
(Executive dysfunction) 1 0.359* 0.593 *
Orbitofrontal
(Disinhibition) 0.359 * 1 0.516 **
Anterior cingulate (Apathy) 0.593 ** 0.516** 1
* p < 0.05; ** p < 0.01.
These results are consistent with those obtained in the additional analyses. Based
on the results obtained in the executive dysfunction subscale (dorsolateral prefrontal
syndrome) and employing as a cut-off point the direct score considered clinically high
(equal to or greater than 60), the patients were divided into two groups: (1) high in executive
dysfunction (H-ED) and (2) low in executive dysfunction (L-ED). When comparing the
scores of the two groups on the two NS dimensions, the H-ED group obtained significantly
higher scores both in expressive deficits (U = −2.803, p = 0.003, r = 0.5) and disordered
relationships/avolition (U = −2.013, p = 0.045, r = 0.35) (see Figure 1).
Finally, we considered it relevant to analyze the percentage of patients who presented
a clinically significant score for each syndrome, since this could corroborate the behavioral
abnormalities related to the frontal system in patients with a predominance of NS. Re-
garding the dorsolateral syndrome (executive dysfunction subscale), we found that 72.7%
presented a clinically significant score; regarding the orbitofrontal syndrome (disinhibition
subscale), 33.3% of the patients presented a clinically significant score; and concerning
anterior cingulate syndrome (apathy subscale), 69.7% of patients obtained a clinically
significant score (see Figure 2).
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3.2. Influence of Sociodemographic and Clinical Variables on the Negative Symptoms
The sociodemographic and clinical characteristics of the sample are displayed in
Table 1. Concerning the disordered relationships/avolition dimension, no significant dif-
ferences were found according to age, gender, years of education, medication type or
clinical setting (see Table 3). However, with regards to the dimension of expressive deficits
(see Table 4), we found that patients with a short evolution, compared to those with a
long evolution, showed significantly lower scores in this dimension of NS. No significant
differences were found according to the rest of the demographic or clinical variables.
Table 3. Influence of sociodemographic and clinical variables on the severity of NS of the disordered
relationships/avolition.
Disordered Relationships/Avolition
Mean SD Statistics p
Age <44.4 9.40 7.77 U = 101.5 0.229>44.4 12.8 8.26
Gender
Male 12.42 8.66















In hospital 9.67 5.93
U = 114.5 0.464Outpatient 13.13 10.01
Years of
evolution
Short evolution 11.56 7.96
U = 129.0 0.817Long evolution 10.94 8.45
Table 4. Influence of sociodemographic and clinical variables on the severity of NS of the expressive
deficits dimension.
Expressive Deficits
Mean SD Statistics p
Age <44.4 13.80 13.5 U = 119.5 0.580>44.4 14.44 10.5
Gender
Male 14.54 12.88















In hospital 13.44 12.66
U = 119.0 0.580Outpatient 15.00 10.99
Years of
evolution
Short evolution 18.19 12.91
U = 77.5 0.034 *Long evolution 10.35 9.44
* p < 0.05.
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3.3. Social Functioning and Negative Symptoms
Regarding the two social functioning scores (Social Functioning Scale (SFS-HI) and
the domain Social relationships of the quality of life questionnaire (WHOQOL-BREF), a sig-
nificant correlation was found between the scores of the disordered relationships/avolition
dimension and the scores of the Social relationships domain of the quality of life ques-
tionnaire (WHOQOL-BREF) (rho = −0.4, p = 0.03). The correlations with the remaining
variables were null (see Table 5).
Table 5. Correlations between scores on the two dimensions of negative symptoms (disordered
relationships/avolition and expressive deficits), and scores on Social Functioning (SFS-HI) and the
domain Social relationships of the quality of life questionnaire (WHOQOL-BREF).
Social Functioning (SFS-HI) Social Relationships
Expressive deficits 0.043 0.005
Disordered relationships −0.048 −0.372*
* p < 0.05.
4. Discussion
The objectives of the present study were threefold. First, we aimed to explore the
relationships between the two dimensions of NS symptoms with the behavioral alterations
associated with three frontal behavioral syndromes: dorsolateral prefrontal syndrome
(executive dysfunction subscale), orbitofrontal syndrome (disinhibition subscale) and
anterior cingulate syndrome (apathy subscale). Our second goal was to analyze whether
the two dimensions of NS (disordered relationships/avolition and expressive deficits) are
influenced by clinical and sociodemographic variables. Finally, we aimed to explore the
relationship between the two dimensions of NS and social functioning.
4.1. Negative Symptoms and Frontal Behavioral Syndromes
Regarding our first objective, we have used the FrSBE self-report questionnaire, the
theoretical development of which was prompted by extensive previous research on frontal
lobe circuits. The FrSBE is based on the model presented by Mega and Cummings [42]
that reports clinically observable behaviors of the three fronto-subcortical circuits. In
this model, executive dysfunction has been related to the dorsolateral prefrontal circuit,
disinhibited behaviors have been associated with the orbital prefrontal circuit, and apathic
behaviors have been related to the anterior cingulate circuit. Similarly, neuroimaging
studies (voxel-based morphometry and voxel-based analysis of diffusion tensor images)
by authors such as Kawada et al. [43] in patients with schizophrenia have associated the
subscales of the FrSBE with different neuroanatomical correlates. Specifically, they have
found an association between the subscale of executive dysfunction with the left and right
dorsolateral prefrontal cortex. Tsujimoto et al. [44] have found that a higher score on
the apathy subscale is related to the atrophy of different regions of the prefrontal cortex,
including the orbitofrontal cortex, the frontal pole and the dorsolateral prefrontal cortex,
this last area being related to apathy of a cognitive rather than an emotional type.
In our study, patients revealed a positive relationship between the dimension of
expressive deficits and the behavioral alterations associated with the dorsolateral syn-
drome (executive dysfunction subscale). This finding suggests that this symptomatologic
dimension of negative schizophrenia, characterized by a decrease in verbal production,
particularly emotional expression, impoverished language and facial expressions (gestural
and prosodic) could be associated with an alteration in the dorsolateral prefrontal circuit.
Dorsolateral syndrome has been associated mainly with a deterioration of higher cognitive
functions, particularly impairment of executive functions. Patients with this syndrome
show significant deficits in solving complex problems, organizing, planning and carry-
ing out goal-directed activities. These patients tend to appear inattentive, unmotivated,
distracted and dependent on the environment at the behavioral level.
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This finding is consistent with the results of previous studies that report the rela-
tionship between impoverished language, the flattening of affect, and the decrease of
spontaneous movements with the deterioration of the dorsolateral prefrontal cortex, both
at the level of schizophrenia and also in other pathologies such as depression or brain
damage [45].
Regarding the dimension of disordered relationship/avolition (symptoms of apa-
thy/avolition, anhedonia/asociality), we expected to find a relationship with the behav-
ioral alterations associated with the anterior cingulate syndrome (apathy subscale), since
the main affectation of this syndrome is observed at the level of emotional responses,
reflecting a decrease in motivation and difficulties in initiating action, with apathy being
the main behavioral symptom.
However, our results concerning this dimension did not support this notion since a
positive correlation was observed with the alterations related to behaviors of the dorsolat-
eral prefrontal syndrome (executive dysfunction subscale).
This correlation could provide a possible explanation for the symptom of apathy.
Authors such as Zamboni et al. [46] state that this symptom, in general, can result from
several different mechanisms and not only from altered processing of emotion and affect.
Levy and Dubois [47] as well as Stuss and Knight [48] have categorized apathy into three
subtypes: emotional apathy related to orbital brain areas; apathy of self-activation related
to specific lesions of the basal ganglia and the limbic regions; and cognitive apathy or
cognitive inertia related to the dorsolateral, ventrolateral and frontopolar area.
In our study, the correlation found with the behavioral alterations associated with
the dorsolateral prefrontal syndrome (executive dysfunction subscale) could be taken to
indicate that our patients, with predominantly negative schizophrenia, are more prone to
apathy of a cognitive type, since this syndrome has been directly associated with apathy due
to deficits in cognitive functions, expressly those of several executive functions necessary for
goal-directed behavior (GDB), such as working memory, planning and cognitive flexibility.
Similarly, we expected a positive correlation between the dimension of disordered
relationships/avolition with the orbitofrontal syndrome, since this syndrome has been
related to behavioral alterations that affect adequate social functioning. In fact, authors
such as Ohtani et al. [49], in their study using diffusion tensor imaging (DTI), analyzed the
anomalies of the white matter within the connections of the medial orbitofrontal cortex,
finding that these anomalies are related to more severe symptoms of anhedonia-asociality
and avolition-apathy. However, in our study the disordered relationships/avolition symp-
toms were not related to the behaviors associated with the orbitofrontal syndrome. A
possible explanation of our results could be found in that our sample of patients presents a
lower percentage of uninhibited behaviors (33%) (see Figure 2), therefore speculatively the
possibility of less affectation of the connections that make up the orbitofrontal circuit could
be suggested.
These findings are relevant since it can be observed that regardless of the dimension
of predominant NS, that is, expressive deficits (flattening of affect and alogia), or disor-
dered relationships/avolition (symptoms of apathy/avolition, anhedonia/asociality), the
behaviors associated with the dorsolateral prefrontal syndrome would be present. Authors
such as Donohoe and Robertson [50] as well as Frith [51] raise the possibility that deficits
in the dorsolateral area responsible for executive functioning could explain the NS of
schizophrenia, where these NS are the consequence of a disorder of voluntary action, with
impairments in self-initiated behavior, the selection of goal-directed responses and the
inhibition of irrelevant responses.
In this sense, our findings on the association between dysexecutive behaviors (dor-
solateral syndrome) and the two dimensions of NS, expressive deficits and disordered
relationships/avolition, would be in line with neuroimaging studies that have reported the
importance of the dorsolateral circuit in the severity of NS of schizophrenia [52–54]. Brady
et al. [45] attempted to identify the correlates of the brain network with NS by means of the
analysis of functional connectivity in the resting state, finding that the bilateral dorsolat-
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eral prefrontal cortex, especially the right area, significantly covary with NS in this study,
observing how a disruption of the connectivity between the right dorsolateral prefrontal
cortex and the midline of the cerebellum was strongly related to a greater severity of NS.
Similarly, Kawada et al. [43] examined in a sample of patients with schizophrenia
the possible association between abnormalities of brain structures and their relationship
with the behavioral deficits associated with the frontal system (dysexecutive, uninhibited
and apathic behaviors). Although these authors found that patients showed a reduction
in gray matter volume compared to controls in multiple frontal and temporal structures
such as the bilateral dorsolateral prefrontal cortex, ventrolateral prefrontal cortex, medial
prefrontal cortex, medial prefrontal cortex, anterior cingulate and orbitofrontal cortex, they
only observed an association between dysexecutive behaviors and volume reduction in the
dorsolateral prefrontal cortex; the other behaviors (apathic and uninhibited) did not show
significant associations with any brain area.
Although behavioral alterations are not always parallel to brain or neuropsychological
alterations, in fact authors such as Bechara et al. [55] have reported how damage to the
orbital areas alters social behavior but preserves the patient’s cognitive ability to respond
to conventional frontal lobe tests, such as the Wisconsin Card Sorting Test (WCST), this
study by Kawada et al. [43] could suggest that dorsolateral prefrontal cortex pathology
could be the neural basis for dysexecutive behaviors in patients with schizophrenia.
Regarding the clinical involvement of these patients in the three fronto-subcortical
syndromes, we found that a large percentage of our patients presented a clinically signif-
icant score on the three syndromes, especially in the dorsolateral and anterior cingulate
syndrome, with a lower proportion of patients with the orbitofrontal syndrome. The
presence of these syndromes is understood as an indicator of behavioral abnormalities
related to the frontal system [38]. Therefore, these results suggest that a large percentage of
patients with schizophrenia with a predominance of NS present possible involvement of
the three fronto-subcortical circuits.
4.2. Influence of Sociodemographic and Clinical Variables on Negative Symptoms
Regarding our second objective, only the expressive deficits dimension (flattening of
affect and alogia) was influenced by the sociodemographic and clinical variables, although
only in the case of disease duration, in which patients with a longer duration of the disease
(>11 years) presented a significantly lower score on the symptoms than those patients with
fewer years of disease (<11 years).
Although the course and evolution of NS to date is heterogeneous, some studies
such as that of Ergül and Üçok [18] have found a relationship between symptomatic
remission and the expressive deficits dimension score. This remission of symptoms can
have different explanations, such as remission of positive symptoms or symptomatic
improvement thanks to pharmacological treatment. Although in our study neither the type
of therapy received (outpatient or in hospital) nor the pharmacological treatment were
related to this symptomatology, the patients in our study regularly attend psychological
and social therapies, therefore we could speculate that perhaps it is the dimension of
disordered relationships that could benefit the most from this type of intervention.
4.3. Relationship between Social and Functioning Negative Symptoms
Finally, regarding our third objective in terms of social functioning, we found a
negative correlation between the disordered relationships/avolition (symptoms of apa-
thy/avolition, anhedonia/asociality) dimension and the domain of Social relations of the
quality of life questionnaire (WHOQOL-BREF) that assesses the perception of patients
about their personal relationships, social support and sexual activity. In our study, those
participants with higher scores on this dimension were those who also obtained lower
scores on the Social relations domain. This finding suggests that patients with marked
symptoms of apathy, anhedonia and asociality are those patients who also have a worse
perception of their social functioning, specifically a low perception regarding the quality
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of their personal relationships and social support. Ultimately, our results confirm those
of other studies that have found a link between disordered relationships/avolition and
poorer social functioning and more significant deficits in personal relationships [56,57].
These results are relevant due to the importance of social functioning in schizophrenia,
coming to be considered a characteristic element of the disorder and being a key factor for
the maintenance of patients in the community, in addition to being considered a predictor
of the evolution of patients [58].
Regarding the score on the Social Functioning Scale (SFS-HI), we did not find correla-
tions with this scale and the two dimensions of NS; this could be since, unlike the Social
relations domain that specifically analyzes personal relationships, we used the short ver-
sion of the scale that provides a single general score of different aspects in addition to social
functioning, such as isolation/integration, leisure, autonomy or employment/occupation.
5. Conclusions and Implications
In conclusion, the study of NS from a dimensional perspective has allowed us to carry
out a more exhaustive analysis of these two possible subgroups of patients with difficulties
mainly in expression or emotional relationships, which is important given the symptomatic
heterogeneity shown by patients with schizophrenia. This approach, therefore, allows us to
identify more homogeneous clinical subgroups within the broader diagnosis of the disease.
In this regard, the main conclusion that we can draw from our results is the possibility
that the dimension of expressive deficits may be related to a better evolution of the disease
or, as has been suggested in other investigations, with remission of symptoms. Second,
this study allowed us to analyze possible relationships with syndromes of frontal origin;
we specifically highlight the possible involvement of the dorsolateral syndrome in the
two dimensions of NS along with the potential implications of this finding. Dorsolateral
syndrome has primarily been related to impaired executive functioning and, consequently,
to a higher incidence of functional problems, so it would be interesting in future re-
search to analyze whether these two symptomatic dimensions present different patterns of
executive performance.
Additionally, we found that a high percentage of our patients presented the three
fronto-subcortical syndromes. Although these syndromes have been reported in other
populations, such as those with sudden brain damage or dementia, to our knowledge,
this is the first study that has explored the relationship between behavioral abnormalities
related to the frontal system and NS of schizophrenia.
Finally, we have confirmed other reports in the literature showing a possible rela-
tionship between the disordered relationships/avolition dimension and more impaired
social functioning.
Ultimately, these findings and the reports of the previous literature in other patholo-
gies could be taken to indicate the importance of addressing NS and their frontal lobe
dysfunction from a neuropsychological model based on the disconnection syndromes
because the dysfunction of the frontal system can produce similar symptoms in different
pathologies. Numerous studies show a high prevalence of several NS in various patholo-
gies that affect the frontal cortex and subcortical structures, as is the case of fronto-cortical
dementia, depression, dementia of the frontal lobe and acquired brain damage. Therefore,
the approach of studying a set of symptoms present in different diseases could help to
further clarify the causes and areas involved in such disorders.
At a therapeutic level, these results indicate the importance of including possible
deficits in executive functions in neurocognitive rehabilitation programs. For instance, it
would be useful to work with those functions that are affected in dorsolateral prefrontal
syndrome, such as working memory, cognitive flexibility, planning, monitoring tasks and
selecting behaviors to solve problems. Likewise, analyzing NS in this more specific way by
focusing on its two dimensions also allows us, at a therapeutic level, to potentially guide
the design of individualized treatment plans that are adapted to the needs of each patient.
J. Clin. Med. 2021, 10, 3417 14 of 16
In summary, an in-depth exploration of the cognitive deficits of patients with NS from
a two-dimensional perspective could guide us towards better interventions that would
improve the quality of life and functionality of the patients.
6. Limitations
Our findings should be interpreted in the context of various limitations. First, we
have a reduced number of participants, which could have compromised the power of the
study. Second, all the patients included in the study were clinically stable, which would
not allow the results to be extended to patients with psychotic decompensation or those
in acute stages of the disease. Third, this was a cross-sectional study. Considering the
characteristics of the evolution of schizophrenia, the time course during which the patient
was performing the evaluation does not allow us to analyze the possible changes that
they may have undergone throughout the disease. Therefore, the results of our sample
could only be interpreted according to the disease duration (in years). Fourth, our study
did not employ physiological or brain neuroimaging measures that would allow us to
analyze specific patterns of each dimension of NS. Finally, regarding the clinical variable of
pharmacological treatment, the sample has not been divided according to the calculation
of an estimate based on chlorpromazine equivalents.
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